Spots Global Cancer Trial Database for cancer metastatic
Every month we try and update this database with for cancer metastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Web-based Support for Family Caregivers of Patients With Advanced Cancer | NCT05785494 | Family End of Life Cancer Metastat... Chronic Illness | Narstaende.se | 18 Years - | Ersta Sköndal University College | |
| The Italian Registry of Malnutrition in Oncology | NCT06337019 | Cancer Cancer Metastat... | Cohort observat... | 18 Years - | Fondazione IRCCS Policlinico San Matteo di Pavia | |
| The Italian Registry of Malnutrition in Oncology | NCT06337019 | Cancer Cancer Metastat... | Cohort observat... | 18 Years - | Fondazione IRCCS Policlinico San Matteo di Pavia | |
| Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) | NCT04921553 | Cancer Cancer Metastat... NTRK Gene Fusio... NTRK Family Gen... ATIC-ALK Fusion... ALK Fusion Prot... BCR-FGFR1 Fusio... ROS1 Gene Trans... COL1A1-PDGFB Fu... RET Gene Transl... Gene Fusion ROS Gene Transl... BRAF Gene Rearr... FGFR2 Gene Tran... FGFR3 Gene Tran... NTRK1 Gene Tran... | Data collection... | 18 Years - | Centre Leon Berard | |
| UNC Childhood, Adolescent, and Young Adult Cancer Cohort | NCT05096923 | Pediatric Cance... Cancer Cancer Metastat... Survivorship | 1 Year - 39 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors | NCT04987112 | Solid Tumor Cancer Metastat... | CAN1012 | 18 Years - 80 Years | CanWell Pharma Inc. | |
| Colorectal Liver Metastases: Novel Assessment Tools for Technical Resectability | NCT04270851 | Cancer Cancer Metastat... Colorectal Canc... Liver Metastasi... | LiMAx test HepaT1ca magnet... | 16 Years - | University of Manchester | |
| Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) | NCT04921553 | Cancer Cancer Metastat... NTRK Gene Fusio... NTRK Family Gen... ATIC-ALK Fusion... ALK Fusion Prot... BCR-FGFR1 Fusio... ROS1 Gene Trans... COL1A1-PDGFB Fu... RET Gene Transl... Gene Fusion ROS Gene Transl... BRAF Gene Rearr... FGFR2 Gene Tran... FGFR3 Gene Tran... NTRK1 Gene Tran... | Data collection... | 18 Years - | Centre Leon Berard | |
| Informational Meetings for Planning and Coordinating Treatment | NCT04330833 | End of Life Communication Cancer Metastat... | Novel Communica... Enhanced Usual ... | 1 Month - 17 Years | Indiana University | |
| VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer | NCT06337695 | Cancer Cancer Metastat... | Vedolizumab Placebo | 18 Years - | University of Calgary | |
| VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer | NCT06337695 | Cancer Cancer Metastat... | Vedolizumab Placebo | 18 Years - | University of Calgary | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study | NCT04065139 | Gastric Adenoca... Cancer Metastat... Chemotherapy Ef... | Pressurized int... Standard chemot... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib. | NCT04534283 | Cancer Cancer Metastat... BRAF V600E MEK1 Gene Mutat... MEK2 Gene Mutat... ERK Mutation RAF1 Gene Mutat... | Abemaciclib LY3214996 | 18 Years - | Indiana University | |
| Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery | NCT05742438 | Colorectal Canc... Anesthesia Cancer Metastat... Inflammation | Lidocaine IV Dexmedetomidine... intrathecal mor... | 19 Years - | Samsung Medical Center | |
| Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT | NCT04318886 | Cancer Metastat... Family Members | ENABLE Cornerst... | 21 Years - | University of Alabama at Birmingham | |
| Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice | NCT04049188 | Cancer Metastat... | Single-Fraction... | 18 Years - 100 Years | Care Partners | |
| Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery | NCT05742438 | Colorectal Canc... Anesthesia Cancer Metastat... Inflammation | Lidocaine IV Dexmedetomidine... intrathecal mor... | 19 Years - | Samsung Medical Center | |
| A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib. | NCT04534283 | Cancer Cancer Metastat... BRAF V600E MEK1 Gene Mutat... MEK2 Gene Mutat... ERK Mutation RAF1 Gene Mutat... | Abemaciclib LY3214996 | 18 Years - | Indiana University | |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | NCT05103358 | Tumor Tumor, Solid Metastasis Metastatic Canc... Cancer Cancer Metastat... Tumors Neoplasms Neoplasm Metast... Solid Tumor Advanced Solid ... Advanced Cancer Malignant Solid... Malignant Solid... Malignant Neopl... Malignant Tumor TSC TSC1 TSC2 Metastatic Soli... Metastatic Neop... | nab-sirolimus | 12 Years - | Aadi Bioscience, Inc. | |
| Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery | NCT05742438 | Colorectal Canc... Anesthesia Cancer Metastat... Inflammation | Lidocaine IV Dexmedetomidine... intrathecal mor... | 19 Years - | Samsung Medical Center | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study | NCT04065139 | Gastric Adenoca... Cancer Metastat... Chemotherapy Ef... | Pressurized int... Standard chemot... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer | NCT05232409 | Cancer Metastat... Metastatic Soli... | Zeaxanthin Zeaxanthin Plus... | 18 Years - 99 Years | Valley Health System | |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | NCT05103358 | Tumor Tumor, Solid Metastasis Metastatic Canc... Cancer Cancer Metastat... Tumors Neoplasms Neoplasm Metast... Solid Tumor Advanced Solid ... Advanced Cancer Malignant Solid... Malignant Solid... Malignant Neopl... Malignant Tumor TSC TSC1 TSC2 Metastatic Soli... Metastatic Neop... | nab-sirolimus | 12 Years - | Aadi Bioscience, Inc. | |
| IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures | NCT04842266 | Cancer Metastat... Trauma Pathologic Frac... | IlluminOss pelv... IlluminOss pelv... | 21 Years - | Massachusetts General Hospital | |
| Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer | NCT04158362 | Cancer Metastat... | Paclitaxel inje... Capecitabine ta... Letrozole 2.5mg Anastrozole 1mg Fulvestrant Pre... Abemaciclib | 18 Years - | UNICANCER | |
| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | NCT05131815 | Cancer Cancer Metastat... Neoplasms Breast Cancer Lung Cancer Thyroid Cancer Lymphoma Lymphoma, Non-H... Hodgkin Lymphom... Leukemia Sarcoma Skin Cancer Bone Cancer Gynecologic Can... Pancreas Cancer Multiple Myelom... Colorectal Canc... Gastrointestina... Prostate Cancer Glioblastoma Brain Cancer Head and Neck C... | Virtual group b... | 18 Years - 39 Years | Cedars-Sinai Medical Center | |
| Improving Public Cancer Care by Implementing Precision Medicine in Norway | NCT04817956 | Cancer Metastat... | Atezolizumab | 16 Years - | Oslo University Hospital | |
| UNC Childhood, Adolescent, and Young Adult Cancer Cohort | NCT05096923 | Pediatric Cance... Cancer Cancer Metastat... Survivorship | 1 Year - 39 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT | NCT04318886 | Cancer Metastat... Family Members | ENABLE Cornerst... | 21 Years - | University of Alabama at Birmingham | |
| Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Bone Metastases | NCT06391242 | Cancer Metastat... | Standard Conven... Stereotactic Bo... | 18 Years - | Canadian Cancer Trials Group | |
| Study of AK112 in the Treatment of Advanced Gynecological Tumors | NCT04870177 | Gynecologic Can... Cancer Metastat... Ovarian Neoplas... Cervical Neopla... Endometrial Neo... | AK112 | 18 Years - 75 Years | Akeso | |
| An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors | NCT04443088 | Cancer Solid Tumor, Ad... Cancer Metastat... Solid Carcinoma Solid Tumor, Un... Tumor, Solid | INV-1120 Pembrolizumab | 18 Years - | Shenzhen Ionova Life Sciences Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
